Efficacy of an Anorectal Fistula Plug With Sealing of the Internal Opening as a Treatment for Perianal Fistula
Primary Purpose
Fistula in Ano
Status
Terminated
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
CuraSeal Percutaneous Intraluminal Closure System
Sponsored by
About this trial
This is an interventional treatment trial for Fistula in Ano
Eligibility Criteria
Inclusion Criteria:
Patients who are psychologically stable and suitable for intervention and able to provide informed consent
- Patients who are willing and competent to fill in questionnaires and undergo investigations at various time points during the study
- Patients with an idiopathic extra and trans-sphincteric perianal fistula.
Exclusion Criteria:
- Patients aged less than 18 or >80 years.
- Patients unfit to undergo general or spinal anaesthesia.
- Patients with a supra-levator fistula.
- Patients with a rectovaginal fistula.
- Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis).
- Patients with a fistula secondary to trauma, foreign body, developmental cyst or pelvic irradiation.
- Patients who are immunosuppressed.
Sites / Locations
- London North West Healthcare NHS Trust
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
investigational arm
Arm Description
Outcomes
Primary Outcome Measures
fistula healing
clinical and radiological healing
Secondary Outcome Measures
adverse effects or perioperative compilations related to device
Full Information
NCT ID
NCT03381365
First Posted
December 18, 2017
Last Updated
January 15, 2020
Sponsor
London North West Healthcare NHS Trust
1. Study Identification
Unique Protocol Identification Number
NCT03381365
Brief Title
Efficacy of an Anorectal Fistula Plug With Sealing of the Internal Opening as a Treatment for Perianal Fistula
Official Title
A Pilot Study to Assess the Efficacy of an Anorectal Fistula Plug With Sealing of the Internal Opening (Curaseal AF) as a Treatment for Perianal Fistula
Study Type
Interventional
2. Study Status
Record Verification Date
September 2017
Overall Recruitment Status
Terminated
Why Stopped
low recruitment
Study Start Date
September 1, 2016 (Actual)
Primary Completion Date
December 31, 2018 (Actual)
Study Completion Date
December 31, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
London North West Healthcare NHS Trust
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The investigators aim to assess the efficacy of the Curaseal anal plug in patients with idiopathic uncomplicated fistulous tracts. Healing of the fistula tract will be assessed both clinically and radiologically with MR imaging.
Detailed Description
Perianal fistula is a challenging condition for colorectal surgeons. Achieving a favourable balance between healing and incontinence is the key to success. Surgeons have adopted many methods to close off this abnormal tract, which include laying opening, use of setons, advancement flaps and permanent stoma. A more recent approach has been the use of devices or substances to block the tract in the hope that it will seal off. Most of the devices that have been used to close the tract have not proved to be as effective in healing as a lay open with high rates of fistula persistence. A major failure of the devices has been their early expulsion and their inability to seal off the internal opening.
The new Curaseal plug may be able to overcome these shortcomings. This plug has a disc to seal the internal opening, with a suture to be placed at the external opening, which may prevent it falling out and ensure internal opening closure.
The investigators aim to assess the efficacy of the Curaseal anal plug in patients with idiopathic uncomplicated fistulous tracts. Healing of the fistula tract will be assessed both clinically and radiologically with MR imaging.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fistula in Ano
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
6 (Actual)
8. Arms, Groups, and Interventions
Arm Title
investigational arm
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
CuraSeal Percutaneous Intraluminal Closure System
Primary Outcome Measure Information:
Title
fistula healing
Description
clinical and radiological healing
Time Frame
1 year
Secondary Outcome Measure Information:
Title
adverse effects or perioperative compilations related to device
Time Frame
within first year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients who are psychologically stable and suitable for intervention and able to provide informed consent
Patients who are willing and competent to fill in questionnaires and undergo investigations at various time points during the study
Patients with an idiopathic extra and trans-sphincteric perianal fistula.
Exclusion Criteria:
Patients aged less than 18 or >80 years.
Patients unfit to undergo general or spinal anaesthesia.
Patients with a supra-levator fistula.
Patients with a rectovaginal fistula.
Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis).
Patients with a fistula secondary to trauma, foreign body, developmental cyst or pelvic irradiation.
Patients who are immunosuppressed.
Facility Information:
Facility Name
London North West Healthcare NHS Trust
City
London
ZIP/Postal Code
HA1 3UJ
Country
United Kingdom
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Efficacy of an Anorectal Fistula Plug With Sealing of the Internal Opening as a Treatment for Perianal Fistula
We'll reach out to this number within 24 hrs